FPFS
BOLD

First Personal Financial Services’s Audentes Therapeutics, Inc BOLD Stock Holding History

First Personal Financial Services’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-216
Closed -$6K – 1014
2018
Q1 		$6K Buy
+216
New +$7.31K ﹤0.01% 907

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Personal Financial Services's BOLD Position: Q2 2018 in Review

First Personal Financial Services sold out of Audentes Therapeutics, Inc (BOLD) in Q2 2018, closing a stake of 216 shares — an estimated $6K sold.

First Personal Financial Services first reported a position in BOLD in Q1 2018 and held it in 1 quarter. The position peaked at $6K in Q1 2018. 123 funds tracked by Wall St. Rank hold BOLD as of Q2 2018.

  • First Personal Financial Services reported no remaining Audentes Therapeutics, Inc position as of Q2 2018 after selling out during the quarter.
  • First Personal Financial Services sold 216 Audentes Therapeutics, Inc shares in Q2 2018, an estimated $6K.
  • First Personal Financial Services first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 1 quarter.
  • First Personal Financial Services's Audentes Therapeutics, Inc position peaked at $6K in Q1 2018.
  • 123 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.